Literature DB >> 17283190

Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.

Aldona L Baltch1, William J Ritz, Lawrence H Bopp, Phyllis B Michelsen, Raymond P Smith.   

Abstract

We investigated the antistaphylococcal activity of daptomycin, vancomycin, oxacillin, gentamicin, and rifampin in human monocyte-derived macrophages. Compared with vancomycin and oxacillin, daptomycin had the most rapid and greatest antibacterial activity, but that of oxacillin was most sustained. The combination of daptomycin, gentamicin, and rifampin was most effective intracellularly, while daptomycin plus gentamicin and the three-drug combination were most effective extracellularly, completely eliminating viable Staphylococcus aureus.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17283190      PMCID： PMC1855516          DOI： 10.1128/AAC.00973-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Antimicrobial tissue concentrations.

Authors:  Ping Liu; Hartmut Derendorf
Journal:  Infect Dis Clin North Am       Date:  2003-09       Impact factor: 5.982

2.  Daptomycin structure and mechanism of action revealed.

Authors:  Jason Micklefield
Journal:  Chem Biol       Date:  2004-07

3.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

4.  Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.

Authors:  Kimberly D Leuthner; Chrissy M Cheung; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2006-06-20       Impact factor: 5.790

5.  In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.

Authors:  F Cilli; S Aydemir; A Tunger
Journal:  J Chemother       Date:  2006-02       Impact factor: 1.714

Review 6.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors:  Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

7.  In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins.

Authors:  Eric Brouillette; Gilles Grondin; Lulzim Shkreta; Pierre Lacasse; Brian G Talbot
Journal:  Microb Pathog       Date:  2003-10       Impact factor: 3.738

8.  Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.

Authors:  Maritza Barcia-Macay; Cristina Seral; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

10.  Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.

Authors:  Helio S Sader; Jennifer M Streit; Thomas R Fritsche; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2004-11       Impact factor: 2.803
View more
  15 in total

1.  Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.

Authors:  Aldona L Baltch; William J Ritz; Lawrence H Bopp; Phyllis Michelsen; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

2.  The effectiveness of negative pressure therapy on infected wounds: preliminary results.

Authors:  Federico Lo Torto; Marco Ruggiero; Paola Parisi; Zachary Borab; Manuel Sergi; Bruno Carlesimo
Journal:  Int Wound J       Date:  2017-02-15       Impact factor: 3.315

3.  Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Claira Arul Aruldass; Santhana Raj Louis Masalamany; Chidambaram Kulandaisamy Venil; Wan Azlina Ahmad
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-31       Impact factor: 4.223

Review 4.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations.

Authors:  Hoang Anh Nguyen; Olivier Denis; Anne Vergison; Paul M Tulkens; Marc J Struelens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

6.  Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus in vitro.

Authors:  Dae-Ki Joung; Ok-Hwa Kang; Yun-Soo Seo; Tian Zhou; Young-Seob Lee; Sin-Hee Han; Su-Hyun Mun; Ryong Kong; Ho-Jun Song; Dong-Won Shin; Dong-Yeul Kwon
Journal:  Exp Ther Med       Date:  2016-03-31       Impact factor: 2.447

Review 7.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Reconstructed Apoptotic Bodies as Targeted "Nano Decoys" to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.

Authors:  Rajendran J C Bose; Nagendran Tharmalingam; Fernando J Garcia Marques; Uday Kumar Sukumar; Arutselvan Natarajan; Yitian Zeng; Elise Robinson; Abel Bermudez; Edwin Chang; Frezghi Habte; Sharon J Pitteri; Jason R McCarthy; Sanjiv S Gambhir; Tarik F Massoud; Eleftherios Mylonakis; Ramasamy Paulmurugan
Journal:  ACS Nano       Date:  2020-05-04       Impact factor: 18.027

Review 9.  Intrinsic and acquired resistance mechanisms in enterococcus.

Authors:  Brian L Hollenbeck; Louis B Rice
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

10.  Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.

Authors:  Jhih-Hang Jiang; Anton Y Peleg
Journal:  Genes (Basel)       Date:  2015-11-30       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.